Background: An association between Kaposi's sarcoma associated herpesvirus (KSHV) and the pathogenesis of multiple myeloma (MM) was postulated recently. The dendritic cells of patients with MM were proposed to be infected with the virus.
Introduction
The detection of KSHV DNA in bone marrow derived dendritic cells, cultured in Iscove's modified Dulbecco's medium supplemented with 10% horse serum and 10% fetal calf serum, in 15 out of 15 patients with MM and in two out of eight patients with MGUS [1] raised the question of a causative role of the virus in the pathogenesis of MM. KSHV, first found in AIDS-associated Kaposi's sarcoma [2] , belongs to the family of gammaherpesviruses and is closely related to Epstein-Barr virus and herpesvirus saimiri [3] . The KSHV genome contains sequences homologous to human interleukin-6 (IL-6) [4, 5] , whose biological activity as growth factor was proven in IL-6 dependent cell culture systems [6] . IL-6 as a key growth factor in MM stimulates the growth of the malignant cells [7] [8] [9] and prevents them from apoptosis [10] . The Los Angeles group substantiated the hypothetical association between KSHV and MM with the demonstration of the presence of KSHV in 7 out of 20 leukapheresis products, in six out of seven fresh bone marrow biopsies and in peripheral blood from patients with MM after enrichment for CD83+ and CD68+ dendritic cells [11] [12] [13] . In contrast, Tarte et al. [14] examined dendritic cells obtained after culturing apheresis cells in X-VIVO 15 medium with GM-CSF, TNFa and IL-4 for the presence of KSHV DNA. In only 1 out of 11 samples analysed KSHV DNA could be detected. Furthermore, apheresis cells from 10 patients with MM cultured in RPMI 1640 medium supplied with GM-CSF and IL-4 revealed no positivity for KSHV as well [15] . Because of these controversial data, we cultured bone marrow MNC from patients with MM with the culture conditions used by Rettig et al. [1] . Furthermore, two additional protocols containing growth factors supporting the generation of dendritic cells were used. The presence of KSHV was examined with a nested PCR assay followed by KSHV specific hybridisation.
Patients and methods

Patients
Twenty-two patients with MM and one patient with MGUS were enrolled into the study. The characteristics of the 23 patients are summarized in Table 1 . According to the classification of Durie and Salmon [16] , 74% of the patients with MM were in advanced stages of the disease. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23   44  54  59  49  40  44  55  58  53  59  45  37  37  55  62  65  50  59  46  58  58  49 47 [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [20] [21] [22] [23] , was the one used by Rettig et al. [1] , and originally derived from Gartner and Kaplan [17] . Culture type 2 was basically set up according toTarte et al. [18] , with minor modifications in the cytokine concentrations. While TNFa and GM-CSF were used in the same concentration, IL-4 was added with 10 ng/ml instead of 25 ng/ml (rhu TNFa, rhu GM-CSF and rhu IL-4 PromoCell, Heidelberg, Germany). MNC of 14 patients (patients 1-3, 5-6, 10-14, 20-23) were cultured with these conditions. The third culture type was essentially the one described by Pfeiffer et al. [19] . MNC of nine patients received these culture conditions (patients 1-3, 10, 11, 13, 18-21). For culture type 2 and 3 the non-adherent cells were removed after two hours incubation at 37 °C and the remaining cells were washed twice with phosphate-buffered saline (PBS, GibcoBRL Life Technologies, Eggenstein, Germany). For all culture types, medium was changed on day 6 and cells were harvested on day 13. Light microscope examination was used to identify dendritic cells by their characteristic morphology. Adherent cells were detached after incubation with 4 ml of 0.25 M EDTA, pH 8.0 (GibcoBRL Life Technologies) in RPMI medium for 15 min at 37 °C and with the use of a cell scraper (Costar). Both the adherent and the non-adherent cell fractions were combined and analysed together. Polymerase chain reaction DNA from the cultured cells was isolated using DNAzol® (DNAzol Reagent, GibcoBRL Life Technologies) according to the manufacturer's instructions. Concentration of the DNA was quantitated by optical density (OD) measurement. The integrity of the isolated DNA was confirmed by ethidium bromide agarose gel electrophoresis. PCR analyses were performed using a nested PCR assay comprising the K.S 330 2 33 sequence of the virus genome [1, 2] , Depending on the cell numbers harvested, initial amplification was done with 0.05-2 ug DNA in a volume of 50 ul in the presence of 0.8 mM of each primer, 2 mM MgC12. 200 mM of each nucleotide, 5 ml 10 PCR buffer (GeneAmp 10 x PCR buffer, Perkin Elmer, Weiterstadt, Germany) and 2.5 U of AmplitaqGold (Perkin Elmer). Primers used were the following: 5'-ctc get cgc cca ggt aca tgg aca gat cgt caa g-3'; 5'-ctg gtt egg ccc acg gac tac ate caa att atg cag-3' [2] . The first round of amplification consisted of a preheating step at 94 °C for 7 min, 55 cycles at 95 °C for 1 min and 65 °C for 1 min followed by a final extension at 72 °C for 5 min. Three ul aliquots of first round amplification were re-amplified for 40 cycles at 95 °C for 1 min, 62 °C for 1 min and 72 °C for 1.5 min with a final extension at 72 °C for 5 min with the following primers: 5'-ctc get cgc cca gat ccg tgt tgt eta cgt cca g-3': 5'-ctg gtt egg ccc att tta gec gaa agg att cca cc-3' [2] . PCR products were electrophoresed on 2% agarose gels containing ethidium bromide. To determine the sensitivity of the PCR assay used KSHV DNA was diluted in placental DNA (Clontech, Palo Alto, CA, USA) down to one copy of the virus genome, equivalent to 230 pg DNA, in a background of 330 000 cells [2, 4] and used for amplification. To test whether the isolated DNA could be amplified PCR was performed with an oligonucleotide pair flanking an internal fragment of the bcl-2 gene. 
Southern blotting and hybridisation
After electrophoresis of the whole PCR assay, DNA was transferred to nylon membranes (Nylon Membranes, positively charged, Boehnnger Mannheim, Germany) in 0.4 N NaOH. Hybridisation was performed with a digoxigenin-labeled KSHV specific oligonucleotide (5'-ttg gag tag atg tgg tac ace aac a-3', [21] ). Oligonucleotides were labeled with digoxigenin-2'-deoxyundine-5'-tnphosphate using terminal transferase (Boehringer) according to the manufacturer's instructions. Prehybridisation for 30 min at 55 °C was followed by hybridisation for five hours at 55 °C (hybridisation solution: DIG easy hyb granules, Boehringer). Blots were subsequently washed twice in 2 x SSC/0.1% SDS (1 x SSC, 0.15 M NaCl -0.015 M Na-Citrate/SDS, sodiumdodecylsulfate) for 5 min, and two times in 0.1 x SSC/0.1% SDS for 10 min, respectively. Blots were developed using CSPD as a chemiluminescence substrate (Chemiluminescence Substrate for Alkaline Phosphatase, Boehringer Ingelheim, Hamburg, Germany). For each experiment a positive control of 1 ng of KSHV DNA and a negative control without added DNA were included. Each sample was analysed at least twice.
Results
Generation of dendritic cells from bone marrow MNC:
The number of cells put into culture and the number of cells harvested are summarised in Table 2 . Light micro- 1-59) scopic examination of the cells obtained with the different culture conditions already revealed differences between the three culture types. While the growth factor containing cell cultures led to the formation of large clusters with cells with the typical extensions characteristic for dendritic cells (Figure la) , this could not be observed in culture type 1 in which cells with a more fibroblast-like morphology prevailed (Figure lb) . Dendritic cells were further characterised by their expression of CDla, CD86 and HLA-DR. Cells harvested after culturing with type 2 and 3 showed the following characteristics: CDla+ (type 2: 41%, range 9%-81.8%; type 3: 23.9%, range 16.3%-36%), CD 86+ (type 2: 34.2%, range 19%-60.5%; type 3: 14.8%, range 10.9%-32.4%) und HLA-DR+ (type 2: 70.8%, range 50.7%-94.4%; type 3: 48.7, range 40.1%-59%). In contrast, the proportion of CDla+ cells was very low in the type 1 culture system (median 0.4%, range 0%-2.2%), while a certain percentage of CD14+ cells could be observed (mean 37.8%, range 13%-86%). The expression pattern of the cells obtained with the three culture systems is given in Table 3 .
Validation of the sensitivity of the PCR assay
Dilution series with KSHV DNA in placental DNA were prepared in order to demonstrate that the PCR assay used was sensitive enough to detect low copy numbers of KSHV. Amounts of DNA equivalent to 200, 100, 50, 20, 10, 5, 2 and 1 copie(s) of KSHV were mixed with 2 ug of placental DNA (equivalent to 330,000 cells) and amplified. While first round amplification was able to detect two copies per reaction tube, second round PCR reproducibly showed PCR positivity with one copy of virus genome in a background of 330,000 cells (data not shown). did not reveal any of the products as KSHV specific (Figure 2b ).
Discussion
Our study was designed to examine the postulated association between KSHV and MM suggested by Rettig et al. [1] . They showed that dendritic cells generated in a stromal culture system were infected with KSHV as proven by PCR in 15 out of 15 patients examined. Using the same culture conditions as described by them none of the samples tested here was positive for KSHV. In addition, two further culture protocols known to give rise to dendritic cells in high purity and number also failed to yield KSHV infected cells. These results are in line with those of Tarte et al. [14] , Cull et al. [15] and Yi et al. [22] . Differences in the seroprevalence of KSHV could not be excluded as a possible explanation for these different findings. The seroprevalences are approximately 5% in the UK [23] , in Germany [24] and in Western Europe (except the Mediterranean countries with a percentage of 10%-20%) compared to the USA with up to 25% [25] . The presence of KSHV is further questioned by recent studies which failed to demonstrate antibodies against KSHV in serum of patients with MM [22] . Using the same culture conditions as described by Rettig et al. [1] makes it also unlikely that stromal cells are the ones infected with KSHV. In conclusion, we have no evidence that bone marrow derived dendritic cells from patients with MM bear KSHV. Thus, they may be used as source for dendritic cells for immunotherapeutic approaches.
